These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1241159)

  • 1. Antimitotic activity of the potent tumor inhibitor maytansine.
    Remillard S; Rebhun LI; Howie GA; Kupchan SM
    Science; 1975 Sep; 189(4207):1002-5. PubMed ID: 1241159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimitotic and antitubulin activity of the tumor inhibitor steganacin.
    Wang RW; Rebhum LI; Kupchan SM
    Cancer Res; 1977 Sep; 37(9):3071-9. PubMed ID: 560248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the in vivo mitotic apparatus by glycols and metabolic inhibitors.
    Rebhun LI; Jemiolo D; Ivy N; Mellon M; Nath J
    Ann N Y Acad Sci; 1975 Jun; 253():362-77. PubMed ID: 1096720
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoids.
    Kupchan SM; Sneden AT; Branfman AR; Howie GA; Rebhun LI; McIvor WE; Wang RW; Schnaitman TC
    J Med Chem; 1978 Jan; 21(1):31-7. PubMed ID: 563462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of new antimitotic antibiotics, ansamitocins, on the growth of murine tumors in vivo and on the assembly of microtubules in vitro.
    Ootsu K; Kozai Y; Takeuchi M; Ikeyama S; Igarashi K; Tsukamoto K; Sugino Y; Tashira T; Tsukagoshi S; Sakurai Y
    Cancer Res; 1980 May; 40(5):1707-17. PubMed ID: 6245801
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding of maytansinoids to tubulin.
    York J; Wolpert-DeFilippes MK; Johns DG; Sethi VS
    Biochem Pharmacol; 1981 Dec; 30(23):3239-43. PubMed ID: 7317106
    [No Abstract]   [Full Text] [Related]  

  • 7. Change in the heterogeneous distribution of tubulin isotypes in mitotic microtubules of the sea urchin egg by treatment with microtubule depolymerizing or stabilizing drugs.
    Oka MT; Arai T; Hamaguchi Y
    Cell Struct Funct; 1991 Apr; 16(2):125-34. PubMed ID: 1860140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule-disrupting effects of gallium chloride in vitro.
    Perchellet EM; Ladesich JB; Collery P; Perchellet JP
    Anticancer Drugs; 1999 Jun; 10(5):477-88. PubMed ID: 10477168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caulerpenyne interferes with microtubule-dependent events during the first mitotic cycle of sea urchin eggs.
    Pesando D; Huitorel P; Dolcini V; Amade P; Girard JP
    Eur J Cell Biol; 1998 Sep; 77(1):19-26. PubMed ID: 9808285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of maytansine to tubulin: competition with other mitotic inhibitors.
    Lin CM; Hamel E; Wolpert-DeFilippes MK
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):443-51. PubMed ID: 7255878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maytansine inhibits nucleotide binding at the exchangeable site of tubulin.
    Huang AB; Lin CM; Hamel E
    Biochem Biophys Res Commun; 1985 May; 128(3):1239-46. PubMed ID: 4004859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of cytokinesis in sea urchin embryos by low concentrations of stypoldione, a marine natural product that reacts with sulfhydryl groups.
    O'Brien ET; Asai DJ; Jacobs RS; Wilson L
    Mol Pharmacol; 1989 May; 35(5):635-42. PubMed ID: 2725473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
    Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E
    Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of size and birefringence of the in vivo mitotic apparatus.
    Rebhun LI; Mellon M; Jemiolo D; Nath J; Ivy N
    J Supramol Struct; 1974; 2(2-4):466-85. PubMed ID: 4373619
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitubulin activities of ansamitocins and maytansinoids.
    Ikeyama S; Takeuchi M
    Biochem Pharmacol; 1981 Sep; 30(17):2421-5. PubMed ID: 21043240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhizoxin binding to tubulin at the maytansine-binding site.
    Takahashi M; Iwasaki S; Kobayashi H; Okuda S; Murai T; Sato Y
    Biochim Biophys Acta; 1987 Dec; 926(3):215-23. PubMed ID: 3120782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
    Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
    Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on macrocyclic lactone antibiotics. XI. Anti-mitotic and anti-tubulin activity of new antitumor antibiotics, rhizoxin and its homologues.
    Takahashi M; Iwasaki S; Kobayashi H; Okuda S; Murai T; Sato Y; Haraguchi-Hiraoka T; Nagano H
    J Antibiot (Tokyo); 1987 Jan; 40(1):66-72. PubMed ID: 3606749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
    Derry WB; Wilson L; Jordan MA
    Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of fluorescently labeled tubulin injected into sand dollar eggs from fertilization through cleavage.
    Hamaguchi Y; Toriyama M; Sakai H; Hiramoto Y
    J Cell Biol; 1985 Apr; 100(4):1262-72. PubMed ID: 3920225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.